Thursday, June 22, 2017
 
 
Molecular Diagnostic Market: Awareness Of Diagnosis Leads To Self-Care Management
According to MarketIntelReports ?Global Molecular Diagnostic Market by Manufacturers, Regions, Type and Application, Forecast to 2021...
 
New Phase 3 Data Show Anti-TNF Alpha SIMPONI ARIA® (golimumab) Significantly Improved Arthritis And Skin Manifestations In Patients With Active Psoriatic Arthritis
MADRID, June 14, 2017 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today results from the pivotal Phase 3 GO-VIBRANT study that showed the significant efficacy of the intravenously administered anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI ARIA®
 
Xealth Launches Digital Prescribing Platform and Announces $8.5M in Funding From DFJ, Providence, UPMC, Hennepin, and Froedtert
SEATTLE, June 14, 2017 /PRNewswire/ -- Xealth, a digital health care startup, today announced an $8.5M investment led by DFJ and the launch of its digital prescribing and analytics platform. The Xealth platform, which is bei.....
 
When Treating Eczema in Babies, the ?Wet Look is In

New York, NY (PRWEB) June 14, 2017

 
Results from CRIB study on CIMZIA® (certolizumab pegol) demonstrate minimal to no placental transfer of drug from mother to infant during third trimester of pregnancy

BRUSSELS, June 13, 2017 /PRNewswire/ -- UCB today presented results from CRIB, a pharmacokinetic study designed to assess if CIMZIA® (certolizumab pegol) is transferred across the placenta from pregnant women to their infants. The study used a sensitive immunoassay designed specifically to measure CIMZI.....

 
Surgeons at Children's Hospital of Philadelphia Separate Twin Girls Joined at Heads
PHILADELPHIA, June 13, 2017 /PRNewswire-USNewswire/ -- On Tuesday, June 7th, surgeons at Children's Hospital of Philadelphia (CHOP) successfully completed the separation of 10-month-old conjoined twins Erin and Abby Delaney
 
New York Blood Center Announces New Trustees
NEW YORK, June 13, 2017 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC), a nonprofit, community-based healthcare organization that serves more than 40 million people throughout the country today announced that it has added three new Trustees to its board. Joining the board are Ariel Fishman
 
Hortonworks Congratulates 2017 Americas Data Heroes Award Winners
SAN JOSE, Calif., June 13, 2017 /PRNewswire/ -- DATAWORKS SUMMIT/HADOOP SUMMIT -- Hortonworks, Inc.® (NASDAQ: HDP), a leading innovator of open and connected data platforms, today announced the winners of the 2017 Americas Data Heroes Awards, incl.....
 



AGROAMERICA has invested more than $1.8 million and partnered with the University of Colorado to improve the health of families in rural Guatemala
COATEPEQUE, Guatemala, June 13, 2017 /PRNewswire/ -- The banana grower and shipper, AgroAmerica, created a Center for Human Development (CHD) in south-western Guatemala in 2012, with the objective of improving the health of the families of the AgroAmerica workers and the communities close to t.....
 
SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System®
SAN JOSE, Calif., June 13, 2017 /PRNewswire/ -- SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse Implant System® ("iFuse"), a triangular shaped minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, today announced FDA.....
 
CureVac Extends Global Intellectual Property Estate for Prophylactic mRNA Vaccines
TÜBINGEN, Germany, June 13, 2017 /PRNewswire/ -- CureVac AG, a fully-integrated biotechnology company pioneering mRNA based drugs, today announced it has been granted important patents claiming the use of mRNA-based prophylactic vaccines, significantly adding to the Company's intellectual property (IP) position for its RNAct.....
 
Knowing the Risks of Obesity and Pregnancy

New York, NY (PRWEB) June 13, 2017

 
Windtree Therapeutics and Lee's Pharmaceutical (HK) Limited Enter Into Exclusive License and Collaboration Agreement for Development and Commercialization of KL4 Surfactant Technology Platform in Asia
WARRINGTON, Pa. and SHATIN, Hong Kong, June 12, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee.....
 


 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines